Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects
- PMID: 1349529
- DOI: 10.1007/BF00266363
Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects
Similar articles
-
Debrisoquine oxidation phenotype during neuroleptic monotherapy.Eur J Clin Pharmacol. 1991;41(5):467-70. doi: 10.1007/BF00626371. Eur J Clin Pharmacol. 1991. PMID: 1684751
-
Disposition of the neuroleptics perphenazine, zuclopenthixol, and haloperidol cosegregates with polymorphic debrisoquine hydroxylation.Psychopharmacol Ser. 1993;10:230-7. doi: 10.1007/978-3-642-78010-3_21. Psychopharmacol Ser. 1993. PMID: 8103225 Review. No abstract available.
-
Evidence for the polymorphic oxidation of debrisoquine in the Thai population.Br J Clin Pharmacol. 1990 Feb;29(2):244-7. doi: 10.1111/j.1365-2125.1990.tb03627.x. Br J Clin Pharmacol. 1990. PMID: 2306417 Free PMC article.
-
Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.Acta Psychiatr Scand. 1992 Nov;86(5):364-6. doi: 10.1111/j.1600-0447.1992.tb03281.x. Acta Psychiatr Scand. 1992. PMID: 1485526
-
Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.Prog Clin Biol Res. 1986;214:303-11. Prog Clin Biol Res. 1986. PMID: 2873579 Review. No abstract available.
Cited by
-
Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?Clin Pharmacokinet. 2002;41(7):453-70. doi: 10.2165/00003088-200241070-00001. Clin Pharmacokinet. 2002. PMID: 12083975 Review.
-
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37. doi: 10.1517/17425255.2011.532787. Expert Opin Drug Metab Toxicol. 2011. PMID: 21162693 Free PMC article. Review.
-
Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders.CNS Drugs. 2009;23(3):181-91. doi: 10.2165/00023210-200923030-00001. CNS Drugs. 2009. PMID: 19320528
-
Pharmacokinetics of haloperidol: an update.Clin Pharmacokinet. 1999 Dec;37(6):435-56. doi: 10.2165/00003088-199937060-00001. Clin Pharmacokinet. 1999. PMID: 10628896 Review.
-
Genetically determined adverse drug reactions involving metabolism.Drug Saf. 1993 Jul;9(1):60-77. doi: 10.2165/00002018-199309010-00006. Drug Saf. 1993. PMID: 8347292 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources